0001062993-22-015292.txt : 20220621
0001062993-22-015292.hdr.sgml : 20220621
20220621194942
ACCESSION NUMBER: 0001062993-22-015292
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220617
FILED AS OF DATE: 20220621
DATE AS OF CHANGE: 20220621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DICICCO WENDY F
CENTRAL INDEX KEY: 0001225165
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39271
FILM NUMBER: 221029606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Renovacor, Inc.
CENTRAL INDEX KEY: 0001799850
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 BROADWAY
STREET 2: SUITE 310
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 610-424-2650
MAIL ADDRESS:
STREET 1: 201 BROADWAY
STREET 2: SUITE 310
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Chardan Healthcare Acquisition 2 Corp.
DATE OF NAME CHANGE: 20200306
FORMER COMPANY:
FORMER CONFORMED NAME: Chardan Healthcare Acquisition III Corp.
DATE OF NAME CHANGE: 20200113
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-06-17
0001799850
Renovacor, Inc.
RCOR
0001225165
DICICCO WENDY F
C/O RENOVACOR, INC.
201 BROADWAY, SUITE 310
CAMBRIDGE
MA
02139
0
1
0
0
Chief Financial Officer
Stock Option
1.80
2022-06-17
4
A
0
155325
0
A
2032-06-17
Common Stock
155325
155325
D
The stock option will vest and become exercisable in full on June 17, 2026, with 25% vesting on June 17, 2023, and the remainder vesting in equal monthly installments for the remaining 36 months, subject to the continuous service of the Reporting Person on such vesting dates.
/s/ Joseph Carroll, as attorney-in-fact
2022-06-21